Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
38.21
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Market Briefing For Thursday, May 27
May 27, 2021
Dynamics spurring last year's upside, mostly sputtered with sector-rotation since early February. Periodically breadth broadens out slightly and a move in unison occurs, absent sustainability.
Via
Talk Markets
Good Times For Gold
May 26, 2021
Gold is rising some more, in part as an alternative to crypto.
Via
Talk Markets
FDA May Not Review New COVID-19 Vaccine Emergency Use Requests
May 26, 2021
The FDA, on Tuesday, said that it might decline to review and process new emergency use authorization (EUA) requests for COVID-19 vaccines for the rest of the pandemic...
Via
Benzinga
Exposures
COVID-19
Product Safety
GlaxoSmithKline - Vir Biotech's Antibody COVID-19 Treatment Wins CHMP's Positive Scientific Opinion
May 21, 2021
The European Medicines Agency’s advisory group, Committee for Human Medicinal Products (CHMP), has concluded that GlaxoSmithKline plc (NYSE: GSK) and Vir...
Via
Benzinga
Exposures
COVID-19
Better Mood Day
May 20, 2021
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.
Via
Talk Markets
GSK Exits Respiratory Partner Innoviva In $392M Deal
May 20, 2021
GlaxoSmithKline plc (NYSE: GSK) has agreed to sell 32 million shares in Innoviva Inc (NASDAQ: INVA) back to the royalty management company, raising $392...
Via
Benzinga
Cramer Shares His Thoughts On Marvell, MicroVision, More
May 20, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Cerence Inc (NASDAQ: CRNC) is just one more software company. He doesn't want to play. Cramer wants great...
Via
Benzinga
Better Buy for 2021: GlaxoSmithKline or Sanofi?
May 20, 2021
These are two cheap stocks in an overvalued market.
Via
The Motley Fool
Why ‘Killer’ T Cells Could Boost COVID Immunity In Face Of New Variants
May 20, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
May Or May Not Happen
May 18, 2021
Another day, another drop.
Via
Talk Markets
GlaxoSmithKline-Medicago's COVID-19 Vaccine Candidate Elicit Strong Immune Response
May 18, 2021
Interim Phase 2 trial results of GlaxoSmithKline plc (NYSE: GSK) and its collaborating partner Medicago Inc’s COVID-19 vaccine candidate showed...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
May 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
Another Tough Day For Markets
May 17, 2021
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”
Via
Talk Markets
Sanofi-GSK's COVID-19 Vaccine Candidate Reports Success In Mid-Stage Study
May 17, 2021
Sanofi SA (NASDAQ: SNY) and its collaborating partner GlaxoSmithKline plc (NYSE: GSK) have reported "strong immune responses" in early tests of...
Via
Benzinga
Exposures
COVID-19
73 Firms Going Ex-Dividend Next Week, Including Target, Hershey And GlaxoSmithKline
May 16, 2021
Several well known large cap stocks go ex-dividend next week including the following: Con Ed, Aflac, Target, Chevron, Eversource Energy, Magna International, Hershey Company, Walgreens Boots Alliance,...
Via
Talk Markets
CureVac-GSK's Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Action Against Variants In Animal Study
May 13, 2021
CureVac N.V. (NASDAQ: CVAC) and GlaxoSmithKline Plc (NYSE: GSK) have released positive early data from a preclinical study of its second-...
Via
Benzinga
Exposures
COVID-19
A Down Day
May 12, 2021
The tech wreck continues because inflation will hurt the costly stock sector more than others.
Via
Talk Markets
Fulcrum Therapeutics, Evofem Biosciences Drug Candidates Receive FDA Fast Track Designation
May 12, 2021
The FDA has granted Fast Track designation to Fulcrum Therapeutics Inc's (NASDAQ: FULC) losmapimod for the potential treatment of facioscapulohumeral...
Via
Benzinga
Exposures
Product Safety
VBI Vaccines' Three-Antigen HBV Vaccine Candidate Trial Data Published In Lancet Infectious Diseases
May 12, 2021
VBI Vaccines Inc (NASDAQ: VBIV) has announced that results from Phase 3 PROTECT trial of VBI's prophylactic 3-antigen hepatitis B (HBV) vaccine candidate...
Via
Benzinga
Key Dividend Increases From Last Week, Including PepsiCo, Enbridge, GlaxoSmithKline And Cardinal Health
May 12, 2021
Stocks that raised dividends last week.
Via
Talk Markets
FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children
May 10, 2021
The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Is GlaxoSmithKline Selling Its Income Stream to Royalty Pharma?
May 09, 2021
Apparently, up-front capital is better than royalties on drugs the pharma doesn't have control over.
Via
The Motley Fool
Calm Markets Day
May 07, 2021
Despite seriously disappointing April jobless numbers, markets are gaining all the same.
Via
Talk Markets
Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move
May 06, 2021
The closely watched issue of patent rights for COVID-19 vaccines garnered headlines again as the Biden administration came out in favor of a proposal at the World Trade...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Were Hedge Funds Right About Piling Into American Express Company?
May 03, 2021
Is American Express Company ready to rally soon? The best stock pickers were turning bullish. The number of bullish hedge fund positions rose by 12 in recent months. American Express Company was in 60...
Via
Talk Markets
Novavax Next In List To Start Testing Its COVID-19 Shot In Adolescents
May 03, 2021
Novavax Inc (NASDAQ: NVAX) has initiated a pediatric expansion of its Phase 3 PREVENT-19 trial for NVX-CoV2373, its COVID-19 vaccine candidate. The additional...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2021
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...
Via
Benzinga
Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days
April 30, 2021
Emergent BioSolutions Inc (NYSE: EBS) said it hopes to respond to U.S. regulators within days on how to resolve the problems at its Baltimore plant, which have forced...
Via
Benzinga
Exposures
Product Safety
Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters
April 29, 2021
BioNTech SE's (NASDAQ: BNTX) CEO Ugur Sahin says the company, along with its partner Pfizer Inc (NYSE: PFE), could have data from trials testing the...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.